Barbara Hickingbottom, M.D., J.D.
Senior Vice President, Clinical Development @ Fate Therapeutics
Known information
- Has more than 25 years of life sciences experience in clinical development, medical affairs, and registration strategy
- Led the development of novel biologics, including bispecific antibodies and cytokine therapies, in the areas of oncology and autoimmunity
- Was previously the Chief Medical Officer at AskGene
- Served as Head of Clinical Development at Xencor
- Held senior positions at several leading biopharmaceutical companies
- Received an M.D. from the Tufts University School of Medicine
- Completed her internship and residency in pathology at Stanford
- Received a J.D. from Harvard Law School
- Practiced law in Boston before attending medical school
About Fate Therapeutics
Fate Therapeutics operates advanced manufacturing facilities in San Diego for iPSC-derived cell therapies and collaborates with several institutions to develop cancer treatments.